Literature DB >> 2727461

Diagnostic evaluation of the mentally impaired elderly living at home.

K Engedal1, K Gilje, F Lilleaas.   

Abstract

Of 334 elderly persons aged 75 years and over, drawn from a random sample living at home, 38 were diagnosed as mentally impaired by a GP during an examination in the respondent's home. The GP also made diagnoses as to the cause of the mental impairment. These diagnoses agreed in 79% of cases with the final diagnoses after psychogeriatric assessment, including cerebral CAT-scan, EEG, and ECG investigation. The GP's diagnosis was changed in 8 cases; in 5 primarily due to the findings on the cerebral CAT-scan, and in 3 to the psychogeriatric assessment. The study showed that a GP with some experience in geriatric medicine was able to arrive at a correct clinical diagnosis regarding the cause of acquired mental impairment in elderly people in about 3/4 of the cases. A programme for the GP's diagnostic evaluation of the mentally impaired elderly is outlined.

Entities:  

Mesh:

Year:  1989        PMID: 2727461     DOI: 10.3109/02813438909103663

Source DB:  PubMed          Journal:  Scand J Prim Health Care        ISSN: 0281-3432            Impact factor:   2.581


  3 in total

1.  Antihypertensive medication is associated with less cognitive impairment in the very old with apolipoprotein-E epsilon4 allele.

Authors:  Knut A Hestad; Knut Engedal
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

Review 2.  Clinical judgement by primary care physicians for the diagnosis of all-cause dementia or cognitive impairment in symptomatic people.

Authors:  Samuel T Creavin; Anna H Noel-Storr; Ryan J Langdon; Edo Richard; Alexandra L Creavin; Sarah Cullum; Sarah Purdy; Yoav Ben-Shlomo
Journal:  Cochrane Database Syst Rev       Date:  2022-06-16

3.  Blood Pressure in Different Dementia Disorders, Mild Cognitive Impairment, and Subjective Cognitive Decline.

Authors:  Knut Hestad; Knut Engedal; Peter Horndalsveen; Bjørn Heine Strand
Journal:  Front Aging Neurosci       Date:  2020-08-31       Impact factor: 5.750

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.